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We report here on the interaction of a synthetic 12 residue peptide corresponding to the N-terminal sequence of gp32 from SIV with phospholipid 
bilayers. This peptide has been shown to induce lipid mixing of PC/PE/SM/Chol LUV (large unilamellar vesicles) at pH 7.4 and 37°C [(1992) in: 
Advances in Membrane Fluidity, vol. 6, pp. 365-376, Wiley-Liss]. In the present study, this fusion process was inhibited by the addition of 
lysophosphatidylcholine (1ysoPC) to the lipid bilayer of PCIPEISMIChol LUV. Fourier transform infrared spectroscopy (FTIR) reveals that the 
orientation of the SIV fusion peptide with respect o the lipid acyl chains depends on the presence of 1ysoPC in the lipid bilayer but that the peptide 
secondary structure and the amount of lipid-associated peptides do not depend on the lipid composition. The peptide is obliquely inserted into 
the lipid bilayer of vesicles without IysoPC, whereas it is oriented parallel to the lipid-water interface in the vesicles containing 1ysoPC. The data 
provide evidence that the orientation of the SIV fusion peptide depends on the lipid composition, and that this mediates its fusogenic activity. 
SIV fusion peptide; 1ysoPC; Lipid mixing; FTIR spectroscopy 
1. INTRODUCTION 
Although a great deal of effort has been made to 
understand the genetic and immunological aspects of 
HIV infection, the molecular mechanism of fusion be- 
tween the virus and its host cell remains poorly under- 
stood. Most viral fusogenic proteins contain a short 
N-terminal hydrophobic segment which has been pro- 
posed to interact with the lipid membrane during the 
fusion event [ 1,2]. Mutagenesis tudies have confirmed 
that modifications which disrupt the distribution of the 
hydrophobic amino acids in the N-terminus of influenza 
hemagglutinin [3], gp41 of HIV [4,5] and gp32 of SIV 
[6] inhibit syncytium formation without affecting 
glycoprotein synthesis and processing or receptor bind- 
ing, suggesting that hydrophobicity plays a key role in 
the fusion process. 
Chemically synthesized peptides corresponding to the 
N-terminal segment of influenza virus hemagglutinin 
(HA2) [7-lo], SIV gp32 [11,12] and HIV gp41 [13,14] 
interact with lipid model membranes as a-helical struc- 
tures [7,11,14] and mediate the fusion of lipid vesicles. 
The functional role of these fusogenic peptides was con- 
firmed by the finding of a correlation between their 
fusogenic activity in model systems and their in vivo 
activity [3,13]. Recent data suggest, however, that the 
hydrophobicity of the N-terminal fusion peptide is not 
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the only parameter required for fusion to occur, and 
that the orientation and the secondary structure of the 
peptide at the lipid-water interface play a crucial role 
during the fusion event [15,16]. Burger et al. [17] found 
that while the Influenza wild-type peptide penetrates a 
dioleoyl phosphatidylcholine/dioleoyl phosphatidyl- 
ethanolamine/cholesterol monolayer more effectively 
than a modified peptide, both peptides have similar 
ol-helical content, suggesting that the formation of an 
a-helix is not sufficient for fusion activity. Computer 
analysis predicted that the N-terminal fusogenic do- 
mains of a series of enveloped viral proteins were ori- 
ented obliquely with respect o the lipid-water interface, 
thereby favoring a local membrane destabilization and 
generating new lipid arrangements which are thought to 
be associated with the initial steps of membrane fusion 
[18]. The phase preference of lipids has been related to 
the average shape of the molecules. Bilayer-preferring 
lipids are thought to adopt an overall cylindrical shape. 
In contrast, lipids which readily form the inverted hex- 
agonal (H,,) phase are thought to be conical with the 
polar headgroup at the smaller end of the cone. An 
example of such a lipid is phosphatidylethanolamine 
(PE). Lipids such as lysophosphatidylcholine (lysoPC), 
with a relatively large hydrophilic moiety, prefer micel- 
lar organizations in excess water. The shape-structure 
relationship also applies to mixed lipid systems, such as 
a mixture of equimolar amounts of 1ysoPC and PE, 
which organizes in lamellar structures [19]. Further- 
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more, it should be noted that the concept, besides geo- 
metrical dimensions, takes into account dynamic prop- 
erties of the lipids, as well as headgroup hydratation and 
inter- and intramolecular interactions. Transition be- 
tween the bilayer structure and inverted phases can be 
induced by changes in temperature, pH, ionic strength 
and hydration. The phase change can be induced by the 
addition of divalent cations or polypeptides, for exam- 
ple antiviral activity of structurally different com- 
pounds has been associated to their capacity of increas- 
ing the bilayer/non-lamellar lipid structure transition 
temperature [20-221. 
We have reported previously that a synthetic peptide 
corresponding to the 12 amino acids of the N-terminus 
of gp32 of SIV induces fusion of large unilamellar vesi- 
cles, provided the liposomes contain PE [11,14]. In this 
report, we have investigated the role of the lipids in the 
fusion process induced by the SIV N-terminal 12 residue 
peptide. Lipid mixing of large unilamellar vesicles de- 
pends on the lipid composition and specifically on the 
1ysoPC content. We have also studied the structure and 
the orientation of the peptide associated to LUV in the 
absence and the presence of 1ysoPC. The orientation of 
the peptide in the lipid bilayer determines the observed 
fusogenic activity. 
2. MATERIALS AND METHODS 
2.1. Materials 
Egg PE, egg phosphatidylcholine (PC), cholesterol (Chol), sphin- 
gomyelin (SM), and 1ysoPC were purchased from Sigma Chemical Co. 
(St. Louis, MO, USA). 
N-(Nitrobenzo-2-oxal,3-diazol) phosphatidylethanolamine (NBD- 
PE) and N-(lissamine rhodamine B sulfonyl) phosphatidylethanolam- 
ine (Rh-PE) were from Avanti Polar Lipids Inc. (Birmingham, AL, 
USA). 
2.2. Peptide synthesis 
Peptide was synthesized by solid-phase synthesis using a commer- 
cially available peptide synthesizer (model Biolynx; Pharmacia Bio- 
chrome, Cambridge, UK) and the pre-weighed Fmoc amino acid 
OPFP esters (Pharmacia Biochrome, Cambridge, UK). Acylation rate 
was monitored by the Bioplus software by measuring the release of an 
anionic dye (Acid violet, 17.3 mg/lOO ml dimethylformamide and 0.14 
ml diisopropylethylamine) at600 nm. The peptides were cleaved from 
the resin using trifluoroacetic acid containing 2% anisol and 2% 
ethanedithiol for 2 h followed by ether precipitation. Each peptide was 
purified to more than 95% purity by HPLC on a TSK 120T reverse- 
phase column (7.5 x 300 mm) (Pharmacia, Sweden). The peptides typ- 
ically eluded at 65% acetonitrile (between 65 and 75%) using a linear 
gradient over 90 min from 0 to 80% acetonitrile in 0.1% trifluoroacetic 
acid. The sequence was verified by protein sequencing on an Applied 
Biosystem sequencer. The peptide was dissolved in TFA, and after 
evaporation of the solvent, DMSO was added to give a final peptide 
concentration of 8 x 10e4 M. The stock solutions were stored at 0°C. 
2.3. Vesicles preparation 
Multilamellar vesicles (MLV) were obtained by vortexing a lipid 
film in a Tris buffer (10 mM Tris, 150 mM NaCl, 0.1 mM EDTA, 
0.02% NaN,, pH 7.4). 
Large unilamellar vesicles (LUV) were prepared according to the 
extrusion procedure of Hope et al. [23] using an Extruder (Lipex 
Biomembranes Inc., Vancouver, Canada). Briefly, frozen and thawed 
MLV were extruded 10 times through two stacked polycarbonate 
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membranes with a pore size of 0.1 pm (Nucleopore Corp., Pleasanton, 
CA, USA). 
2.4. Attenuated total reflection fourier-transformed infrared spectros- 
copy (ATR-FTIR) 
A complete description of the procedures allowing the determina- 
tion of the peptide secondary structure and orientation is given in 
Goormaghtigh et al. [24,25] and in Martin et al. [14]. ATR-FTIR 
spectra were recorded at room temperature on a Perkin-Elmer 1720X 
FTIR spectrophotometer quipped with a liquid nitrogen-cooled mer- 
cury cadmium telluride (MCT) detector at a nominal resolution of 4 
cm-‘, encoded every 1 cm-‘. The spectrophotometer was continuously 
purged with air dried on a silica gel column (5 x 130 cm). The internal 
reflection element was a germanium plate (50 x 50 x 2 mm, Harrick 
EJ2121) with an aperature angle of 45”, yielding 25 internal reflec- 
tions. For each spectrum, 128 scan cycles were averaged; in each cycle 
the sample spectra were ratioed against the background spectra of a 
clean germanium plate, using a shuttle to move the sample or reference 
into the beam. For polarization experiments, a Perkin-Elmer gold wire 
grid polarizer was positioned before the sample and the reference. 
2.4.1. Sample preparation 
SIV peptides dissolved in DMSO at a final concentration of 1 
mg/ml, were added to liposomes at a molar lipid/peptide ratio of 300/l 
(2.9 x 10m6 M lipid and lo-* M peptide in a total volume of 200 ~1). 
After overnight incubation at 37”C, the lipid-peptide complex was 
separated from the free peptides by filtration of the sample through 
an anisotropic hydrophilic YMT ultrafiltration membrane (cut off 
30,000 Da) of a Centrifree Micropartition System (Amicon). The 
driving force for ultrafiltration is provided by centrifugation at 
2,000 x g on a fixed-angle rotor of a Sorvall superspeed RCZ-B centri- 
fuge. Oriented multilayers were obtained by slow evaporation of the 
liposomes under N, stream and at room temperature [26] on one side 
of the germanium plate. To differentiate between the cc-helix and the 
random structures, the multilayers were exposed 3 h to N, saturated 
with D,O [27]. 
2.5. Lipid mixing assay 
Lipid mixing was determined by measuring the fluorescence inten- 
sity change resulting from the fluorescence nergy transfer between the 
probes NBD-PE and Rh-PE, as described by Struck et al. [28]. Fluo- 
rescence was monitored using a SLM 8000 spectrofluorimeter with 
excitation and emission slits of 4 nm. Both probes were added to the 
lipid film and LUV were prepared as described above. 
Liposomes containing both probes at 0.6% (molar ratio) each, were 
mixed in a l/9 mole ratio with probe free liposomes at a final lipid 
concentration of 3 x lo-“ M. The initial fluorescence of the 119 (la- 
beled/unlabeled) suspension was taken as 0% fluorescence and the 
100% fluorescence was determined using an equivalent concentration 
of vesicles prepared with 0.06% of each fluorescent phospholipid. The 
suspensions were excited at 470 nm and the NBD fluorescence was 
recorded at 530 nm. 
3. RESULTS 
3.1. Lipid mixing 
Lipid mixing of LUV was monitored by resonance 
energy transfer between NBD-PE and Rh-PE incorpo- 
rated into the liposome membrane [28]. Since small uni- 
lamellar vesicles may have phospholipid packing defects 
that render them more susceptible to fusion [29,30], we 
have investigated the fusion activity of SIV peptide 
using large unilamellar vesicles. 
Addition of the SIV peptide to LUV of PCIPEISMI 
chol (1:1:1:1.5 molar ratio) induces a lipid mixing be- 
tween labeled and unlabeled vesicles (Fig. 1). 
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Fig. 1. Fusion of large unilamellar vesicles (LUV) induced by the 
SIVK! aa peptide at various lipid compositions (the represented curve 
is an average of five independent experiments, and the error on the 
fusion percentage is 2%). Labeled and unlabeled vesicles were mixed 
at a l/9 ratio. At time 0, the peptide in DMSO was added and the 
increase in fluorescence, due to a decrease in fluorescence nergy 
transfer following liposome-liposome fusion was monitored at 530 
nm, pH 7.4 and 37°C. DMSO up to 2% (v/v), which is the maximal 
concentration used, did not modify the fluorescence. The experimental 
conditions were the same for all the lipid compositions tested. The 
total lipid concentration was 3 x 10m4 M and the peptide concentration 
1.3 x lo-’ M. The molar lipid/peptide ratio is 25. 
PE has been shown to form non-lamellar lipid struc- 
tures [31] and to enhance the fusion process when it is 
inserted in the lipid bilayer. In order to define the role 
of PE in the fusion process better, a fraction of PE was 
replaced with 1ysoPC. Fusion did not occur after addi- 
tion of SIV12aa to LUV of PC/lysoPC/PE/SM/Chol 
(1:0.5:0.5: 1: 1.5 molar ratio). This inhibition was not the 
consequence of an insufficient amount of PE, since 
SIV12aa triggers lipid mixing of PC/PE/SM/Chol LW 
(1.5:0.5:1:1.5 molar ratio) (Fig. 1) when 1ysoPC was 
replaced with a corresponding amount of PC. The inhi- 
bition effect observed could be interpreted in terms of 
molecular ‘shape’: 1ysoPC adopts a conical shape com- 
plementary to that of PE [32], and in an equimolar 
mixture of 1ysoPC and unsaturated PE, 1ysoPC stabi- 
lizes the bilayer organization [19]. Moreover, Fig. 1 
suggests that the overall PC-to-PE ratio modulates the 
fusogenic activity: when the PC/PE molar ratio in- 
creases, the fusogenic activity of SIVWT decreases. 
Table I 
Proportion of the different secondary structures of SIV12aa in the 
absence and in the presence of lipid 
SIVWT a-Helix 
(8) 
B-Sheet Random B-Turn 
(8) (%) (%) 
+ DMSO 0 67 f 5 33 f 5 0 
+ PCIPEISh4lChol 35 f 5 23 f 4 35 f 5 7f2 
+ PClPEnysoPCl 
SM/Chol 30 f 5 20 f 4 35 f 5 15 f 5 
The molar lipid/peptide ratio is 200. The percentage of structure is the 
average of three independent measurements. 
3.2. Conformational studies 
The FTIR spectra of SIV12aa peptide dissolved in 
DMSO reveal a high content of /?-sheet structures 
(Table I). After incubation with LUV of PC/PE/SM/ 
Chol (1: 1: 1: 1.5 molar ratio) or LUV of PC/lysoPC/PE/ 
SM/Chol (1:0.5:0.5: 1: 1.5 molar ratio) at a lipid/peptide 
molar ratio of 200, overnight at 37°C the proteo- 
liposomes were separated from free peptide by centri- 
fugation on a centrifree system (cut off 30 kDa). In 
contrast to lipid-free peptide, the lipid-associated pep- 
tide displays some a-helical structure (Table I) charac- 
terized by the appearance of a new large peak centered 
around 1,650 cm-‘. This significant increase of the a- 
helix (& 30%) content is accompanied by a decrease of 
the /?-sheet content (Table I). The structural changes 
observed for LUV of PC/PE/SM/Chol and LUV of PC/ 
PE/LysoPC/SM/Chol are identical (Table I). 
Since the amount of SIV peptide associated with the 
lipid is difficult to evaluate by calorimetric methods, 
because of the small amount of an hydrophobic peptide 
and the presence of lipids, the peptide/lipid ratio was 
determined by evaluating the SamiJSv(C=O)lipid ratio on 
the IR spectra (Samide is the area of amide I measured 
between 1,680 cm-’ and 1,600 cm-‘, and Sv(c=o)epid is the 
area of the lipid v(C=O) band between 1,770 cm-’ and 
1,700 cm-‘) [24]. In the two systems (with and without 
lysoPC), the ratios SamidelSv(C=O)lipid were identical for 
equal lipid concentrations, suggesting that the same 
amount of peptide is associated to the vesicles in the 
presence and in the absence of 1ysoPC in the lipid bi- 
layer. 
The spectra of SIVI 2aa inserted into LUV of PC/PE/ 
SM/Chol (1: 1:1:1.5 molar ratio) and LUV of PC/ 
lysoPC/PE/SM/Chol (1:0.5:0.5:1:1.5 molar ratio) were 
recorded with parallel (0’) and perpendicular (90”) po- 
larized light. The difference spectra 9O”a)” (Fig. 2) 
show a negative deviation around 1,657 cm-’ for the 
helical structure associated with the LUV of PC/lysoPC/ 
PE/SM/Chol which characterizes an orientation of the 
helix axis parallel to the ATR element surface. No devi- 
ation is observed for the a-helix associated to the fused 
LUV of PC/PE/SM/Chol, indicating an oblique orienta- 
tion (Fig. 2). The curve fitting applied to the polarized 
spectra in the amide I region allows for the evaluation 
of the dichroic ratio for the &-helical structure and the 
calculation of a corresponding angle between the long 
axis of the a-helix and a normal to the germanium plate. 
For the helical structure associated to the LUV of PC/ 
lysoPC/PE/SM/Chol the angle is equal to 90 + 5” and 
to 5 ? 5” for LUV of PC/PE/SM/Chol. To determine 
these orientations, a 27” deviation angle between the 
a-helix axis and the C=O transition dipole moment 
described by Rothschild et al. [33] was taken into 
account by introducing an order parameter S,=, = 
(3cos227”-1)/2 so that &,, = Smeasured/SC=o [22,27]. 
The angle between the helix axis and the perpendicular 
to the bilayer we arrive at is therefore a minimum esti- 
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Fig. 2. ATR spectra of SIV12AA i@erted in LUV PC!PE/SM/Chol (A) and LUV PC/PE/lysoPC/SM/Chol (B), recorded with the 90” and 0” 
polarization. The dichroism spectrum obtained by subtracting the (90”-0°) recorded spectra is plotted on the top of the figure, expanded 3-fold 
in the ordinate direction. The arrows indicate the protein amide I (l), the phospholipid 6(CH,) at 1,468 cm-’ (2) and the r&Car) at 1,200 cm’ (3). 
t 
mate, and an orientation of the helix axis closer to this 
perpendicular would result from considering other 
sources of disorder, such as an imperfect parallelism 
between the bilayer and the germanium crystal surface. 
Dichroic ratios corresponding to the /?-sheet structure 
revealed no significant orientation. 
4. DISCUSSION 
It is difficult to imagine that the lipid bilayer structure 
is preserved during the fusion process. PE is known to 
form non-lamellar lipid structures. A relationship be- 
tween non-lamellar lipid structure formation (H,,) and 
the fusion process has been proposed [34]. A number of 
structurally different compounds (cholesterol sulfate 
[21], carbobenzoxy-n-Phe-L-Phe-Gly [20], tromantadine 
[35]) are bilayer stabilizers and show antiviral activity. 
Some of these agents inhibit both model membrane as 
well as viral fusion, suggesting that there is a relation- 
ship between the effect of these drugs on the lipid struc- 
ture and their antiviral activity. Their antiviral activity 
results from a change in the biophysical properties of 
the lipid membrane which is correlated with an increase 
of the bilayer/non-lamellar transition temperature [36]. 
If lipid polymorphism is important in biological proc- 
esses, such as fusion, and if in these processes modula- 
tion of lipid structure is triggered by lipid-protein inter- 
actions, the important question arises as to whether 
proteins will be able to induce changes in lipid phase 
behavior upon entering the membrane through an aque- 
ous phase. Until now, only the measles virus fusion 
peptide has been shown to increase isotropic 3’P reso- 
nance formation, but the peptide apparently produced 
only a modest increase in the rate of fusion. However 
there is a lack of quantitative correlation between pep- 
tide-induced isotropic 31P resonance formation and the 
rates of peptide induced viral fusion [37]. This peptide 
also has a modest activity in lowering the bilayer to the 
hexagonal transition temperature of dielaidoylphospha- 
tidylethanolamine [38]. However, this peptide was 
found to be difficult to complex with phospholipids 
because of its insolubility in a variety of both polar and 
non polar solvents. The SIV12aa fusion peptide was 
shown to lower the hexagonal transition temperature of 
palmitoleoylphosphatidylethanolamine (DPOPE). The 
pure lipid has a hexagonal transition temperature (TJ 
of 43°C. The SIV fusion peptide lowered the T,, by 
29O”/mol fraction. A good linearity of the shift in T,, 
with concentration was observed (to be published). 
We attempted to correlate the fusogenic activity of 
the SIV12aa peptide with its mode of insertion into the 
lipid bilayer. Analysis of the polarized spectra provides 
evidence that the orientation of the a-helix axis depends 
on the presence of 1ysoPC in the lipid bilayer. Without 
1ysoPC in the vesicles membrane, the a-helix axis is 
oriented obliquely in the lipid membrane, whereas in the 
presence of 1ysoPC the a-helix is parallel to the lipid- 
water interface, suggesting its non-insertion into the 
membrane. The data reported here suggest that the 
membrane insertion of the SIV fusion peptide plays an 
important role in vesicle fusion and in viruscell mem- 
brane fusion. It has been proposed that the fusion proc- 
ess involves the penetration of the fusion peptide into 
the target membrane favoring inverted phase forma- 
tion. The fact that the 12aa SIV fusion peptide lowers 
the transition temperature.of DPOPE from a bilayer to 
an hexagonal phase is in agreement with this proposal. 
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